Showing results (91-100 of 217) with videos related to

Sort By:
Pageof 22
Cancers|August 28, 2025
Healthcare Costs by Comorbidity Patterns in Lung Cancer PatientsAlessandra Buja, Massimo Rugge, Marcello Di Pumpo, et al.
Frontiers in Psychology|December 6, 2021
Totally Implantable Venous Access Devices: A Randomized Controlled Trial on the Effect of Psychological Support on Quality of Life and Body Image (BI-PORT)Eleonora Pinto, Elisa Granziera, Matteo Cagol, et al.
Breast Cancer Research and Treatment|May 8, 2013
A randomized, phase II, three-arm study of two schedules of ixabepilone or paclitaxel plus bevacizumab as first-line therapy for metastatic breast cancerHope S Rugo, Mario Campone, Dino Amadori, et al.
Lung Cancer (Amsterdam, Netherlands)|May 3, 2016
Morphological and genetic heterogeneity in multifocal lung adenocarcinoma: The case of a never-smoker womanLaura Bonanno, Fiorella Calabrese, Giorgia Nardo, et al.
Frontiers in Oncology|October 19, 2020
Combined Immunoscore for Prognostic Stratification of Early Stage Non-Small-Cell Lung CancerAlice Boscolo, Francesco Fortarezza, Francesca Lunardi, et al.
Breast (Edinburgh, Scotland)|May 21, 2024
"Positioning of tucatinib in the new clinical scenario of HER2-positive metastatic breast cancer: An Italian and Spanish consensus paper"Pierfranco Conte, Eva Ciruelos, Giuseppe Curigliano, et al.
Anticancer Research|July 3, 2017
Histology-based Combination Induction Chemotherapy for Elderly Patients with Clinical Stage III Non-small Cell Lung CancerGiuseppe L Banna, Hector Josè Soto Parra, Marine Castaing, et al.
Blood|May 13, 2009
Restoration and reversible expansion of the osteoblastic hematopoietic stem cell niche after marrow radioablationMassimo Dominici, Valeria Rasini, Rita Bussolari, et al.
Oncotargets and Therapy|July 7, 2016
Radiological response and survival in locally advanced non-small-cell lung cancer patients treated with three-drug induction chemotherapy followed by radical local treatmentLaura Bonanno, Giulia Zago, Giuseppe Marulli, et al.
European Journal of Cancer (Oxford, England : 1990)|July 5, 2020
Integration of tumour infiltrating lymphocytes, programmed cell-death ligand-1, CD8 and FOXP3 in prognostic models for triple-negative breast cancer: Analysis of 244 stage I-III patients treated with standard therapyMaria Vittoria Dieci, Vassilena Tsvetkova, Gaia Griguolo, et al.
Pageof 22